Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
KLOW is a four-peptide research blend combining KPV (a tripeptide derived from alpha-MSH), GHK-Cu (the copper-binding tripeptide), BPC-157 (the body protection compound 15-residue fragment), and TB-500 (a thymosin beta-4 fragment)
KPV adds three capabilities that GLOW lacks: 1
There is no published study showing that eight or 12 weeks produces a better research outcome than four or six weeks
This suggested that wound healing was nearly complete in the G/D-CuP group with minimal new blood vessel formation on day 12, whereas the M-CuP and G/M-CuP groups, still in the healing process, exhibited increased angiogenesis
US$ 23.66
US$ 21.56
US$ 20.47
US$ 23.55
US$ 27.45
.jpg)
